Hospira doesn't plan to resume production of a key lethal injection drug, which had been made at its massive manufacturing plant in Rocky Mount, after running into opposition from Italian authorities about making the drug in that country.
Halting production of sodium thiopental could disrupt executions in states already struggling with a shortage of the drug.
Hospira wanted to shift production of the drug from Rocky Mount to a plant in Italy that has "state-of-the-art production lines," said spokesman Dan Rosenberg. But Italian authorities insisted the company control the product's distribution to guarantee it wouldn't be used in executions, the Associated Press reports.
After discussions with Italian authorities, with Hospira wholesalers and within the corporation, Hospira decided it couldn't make that promise.


